EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
The paper presents data of a large number of clinical trials meeting the principles of evidence-based medicines, which have dealt with the evaluation of the efficacy of ibandronate in postmenopausal osteoporosis (OP). The administration of its registered formulations (150 mg weekly oral and 3 mg qua...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IMA-PRESS LLC
2010-06-01
|
| Serija: | Современная ревматология |
| Teme: | |
| Online dostop: | http://mrj.ima-press.net/index.php/mrj/article/view/286 |
| Oznake: |
Brez oznak, prvi označite!
|